Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| H3K27me3-mediated epigenetic regulation in pluripotency maintenance and lineage differentiation. | Cell Insight | 2024 | 39072246 | PubTator, text mining | PubMed |
| Proof of concept for a new sensor to monitor marine litter from space. | Nat Commun | 2024 | 38877039 | PubTator, text mining | PubMed |
Molecular Deciphering of Colorectal Cancer: Exploring Molecular Classifications and Analyzing the Interplay among Molecular Biomarkers MMR/MSI, KRAS, NRAS, BRAF and CDX2 - A Comprehensive Literature Review. | Chirurgia (Bucur) | 2024 | 38743828 | PubTator, text mining | PubMed |
| MSC Promotes the Secretion of Exosomal lncRNA KLF3-AS1 to Regulate Sphk1 Through YY1-Musashi-1 Axis and Improve Cerebral Ischemia-Reperfusion Injury. | Mol Neurobiol | 2024 | 38735900 | PubTator, text mining | PubMed |
| Bridging structural and cell biology with cryo-electron microscopy. | Nature | 2024 | 38570716 | PubTator, text mining | PubMed |
| Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. | Cancer Invest | 2024 | 38486421 | PubTator, text mining | PubMed |
| Tyrosine 1-phosphorylated RNA polymerase II transcribes PROMPTs to facilitate proximal promoter pausing and induce global transcriptional repression in response to DNA damage. | Genome Res | 2024 | 38467418 | PubTator, text mining | PubMed |
| Intrafamily heterooligomerization as an emerging mechanism of methyltransferase regulation. | Epigenetics Chromatin | 2024 | 38429855 | PubTator, text mining | PubMed |
| Micropillar arrays, wide window acquisition and AI-based data analysis improve comprehensiveness in multiple proteomic applications. | Nat Commun | 2024 | 38310095 | PubTator, text mining | PubMed |
| Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. | bioRxiv | 2024 | 38293113 | PubTator, text mining | PubMed |
| Efficacy of ramucirumab and subsequent nivolumab therapy in patients with advanced gastric cancer: A retrospective study. | Mol Clin Oncol | 2024 | 38292013 | PubTator, text mining | PubMed |
| Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report. | Drug Target Insights | 2024 | 38283860 | PubTator, text mining | PubMed |
| Network Analysis Performed on Transcriptomes of Parkinson's Disease Patients Reveals Dysfunction in Protein Translation. | Int J Mol Sci | 2024 | 38279299 | PubTator, text mining | PubMed |
| The Hepatokine RBP4 Links Metabolic Diseases to Articular Inflammation. | Antioxidants (Basel) | 2024 | 38275649 | PubTator, text mining | PubMed |
| Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis. | Healthcare (Basel) | 2024 | 38275541 | PubTator, text mining | PubMed |
| Omics Studies of Tumor Cells under Microgravity Conditions. | Int J Mol Sci | 2024 | 38255998 | PubTator, text mining | PubMed |
| Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications. | Materials (Basel) | 2024 | 38255485 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression. | Theranostics | 2024 | 38250042 | PubTator, text mining | PubMed |
| Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic. | EBioMedicine | 2024 | 38244292 | PubTator, text mining | PubMed |
| A miniaturized mode-of-action profiling platform enables high throughput characterization of the molecular and cellular dynamics of EZH2 inhibition. | Sci Rep | 2024 | 38242973 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=12